Na Wang
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Peptidase Inhibition and Analysis
Papers in
-
- Cancer-related molecular mechanisms research 20
- MicroRNA in disease regulation 12
- Protease and Inhibitor Mechanisms 6
- Cancer Genomics and Diagnostics 5
-
- RNA Research and Splicing 7
- RNA modifications and cancer 7
- Circular RNAs in diseases 6
- Co-authors
- Wei Guo (3 shared papers)Jianhui Zhang (4 shared papers)Xia Jin (3 shared papers)Yan Li (2 shared papers)Lizhen Wei (2 shared papers)Yimin Wang (2 shared papers)Denggui Wen (2 shared papers)Shan Kang (3 shared papers)
- Journals
- Frontiers in Oncology (4 papers)Frontiers in Genetics (3 papers)Journal of Cancer Research and Clinical Oncology (2 papers)Microporous and Mesoporous Materials (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Na Wang
102 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 126
- Cancer Research 496
- Oncology 178
- Molecular Biology 402
- Physiology 26
- Immunology 89
Countries citing papers authored by Na Wang
This map shows the geographic impact of Na Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Wang more than expected).
Fields of papers citing papers by Na Wang
This network shows the impact of papers produced by Na Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Wang. The network helps show where Na Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Na Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 140 | |
| 2 | 2005 | 109 | |
| 3 | 2005 | 74 | |
| 4 | 2005 | 32 | |
| 5 | 2019 | 30 | |
| 6 | 2014 | 27 | |
| 7 | 2012 | 26 | |
| 8 | 2015 | 25 | |
| 9 | 2013 | 24 | |
| 10 | 2009 | 24 | |
| 11 | 2013 | 23 | |
| 12 | 2022 | 22 | |
| 13 | 2019 | 21 | |
| 14 | 2022 | 21 | |
| 15 | 2019 | 19 | |
| 16 | 2016 | 19 | |
| 17 | Carcinoma-associated fibroblasts promote the proliferation and metastasis of osteosarcoma by transferring exosomal LncRNA SNHG17. | 2021 | 19 |
| 18 | 2021 | 18 | |
| 19 | The impact of hemoglobin level and transfusion on the outcomes of chemotherapy in gastric cancer patients. | 2015 | 18 |
| 20 | 2024 | 16 |
About Na Wang
Na Wang is a scholar working on Cancer Research, Molecular Biology, Oncology, Electrical and Electronic Engineering and Pulmonary and Respiratory Medicine, having authored 115 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (20 papers), MicroRNA in disease regulation (12 papers), RNA Research and Splicing (7 papers), RNA modifications and cancer (7 papers), Protease and Inhibitor Mechanisms (6 papers), Circular RNAs in diseases (6 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Cancer Research (496 citations), Oncology (178 citations), Molecular Biology (402 citations), Physiology (26 citations) and Immunology (89 citations). Na Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wei Guo, Jianhui Zhang, Xia Jin, Yan Li, Lizhen Wei, Yimin Wang, Denggui Wen, Shan Kang, Juan Wang and Haiyan Wang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Genetics, Journal of Cancer Research and Clinical Oncology, Microporous and Mesoporous Materials and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.